ONTOLOGY REPORT - ANNOTATIONS
| Term: | 2-amino-2-deoxy-D-glucopyranose |
|
| Accession: | CHEBI:47977
|
browse the term
|
| Definition: | A D-glucosamine whose structure comprises D-glucopyranose having an amino substituent at position 2. |
| Synonyms: | related_synonym: | 2-Amino-2-deoxy-D-glucose; C6H13NO5; Chitosamine; D-Glucosamine; InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1; InChIKey=MSWZFWKMSRAUBD-IVMDWMLBSA-N; N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O |
| | alt_id: | CHEBI:4162; CHEBI:47972 |
| | xref_casrn: | 3416-24-8 |
| | xref: | Beilstein:1423209 "Beilstein Registry Number"; ChEMBL:570033 "ChEMBL COMPOUND"; CiteXplore:59831 "PubMed citation"; Gmelin:397125 "Gmelin Registry Number"; KEGG COMPOUND:3416-24-8 "CAS Registry Number"; KEGG COMPOUND:C00329 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D005944 |
| | xref: | Reaxys:1423209 "Reaxys Registry Number" |
| | cyclic_relationship: | is_conjugate_base_of CHEBI:58723 |
|
|
2-amino-2-deoxy-D-glucopyranose
|
| G |
Aacs |
acetoacetyl-CoA synthetase |
|
increases expression |
ISO |
12 |
32,206,863 |
32,250,583 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
increases expression |
EXP |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
EXP |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
affects expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
decreases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
increases expression |
ISO |
6 |
108,089,349 |
108,095,288 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
decreases expression |
ISO |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
|
increases expression |
ISO |
3 |
146,013,995 |
146,057,119 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
multiple interactions |
EXP |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
decreases expression |
EXP |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
multiple interactions |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
increases expression |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
decreases expression |
ISO |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
multiple interactions |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
decreases expression |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
|
increases expression |
EXP |
13 |
87,142,442 |
87,151,783 |
RGD:6480464 |
CTD |
| G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
|
decreases expression |
ISO |
11 |
25,503,380 |
25,548,851 |
RGD:6480464 |
CTD |
| G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
|
multiple interactions |
ISO |
11 |
25,503,380 |
25,548,851 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
decreases cleavage |
ISO |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Ahi1 |
Abelson helper integration site 1 |
|
decreases expression |
ISO |
1 |
16,332,801 |
16,454,055 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
increases expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alg12 |
asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase |
|
decreases expression |
ISO |
7 |
127,109,296 |
127,123,482 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases activity |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases secretion |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases stability |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases degradation |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases localization |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases secretion |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases ubiquitination |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
multiple interactions |
EXP |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
decreases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
multiple interactions |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
decreases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
multiple interactions |
EXP |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
EXP |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf7ip |
activating transcription factor 7 interacting protein |
|
increases expression |
ISO |
4 |
173,566,920 |
173,586,494 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Azin1 |
antizyme inhibitor 1 |
|
decreases expression |
EXP |
7 |
74,159,130 |
74,189,447 |
RGD:6480464 |
CTD |
| G |
Azin1 |
antizyme inhibitor 1 |
|
multiple interactions |
EXP |
7 |
74,159,130 |
74,189,447 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
multiple interactions |
EXP |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
increases expression |
EXP |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
multiple interactions |
EXP |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
increases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
multiple interactions |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
decreases expression |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
EXP |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
multiple interactions |
EXP |
17 |
32,380,199 |
32,689,295 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
decreases expression |
EXP |
17 |
32,380,199 |
32,689,295 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
multiple interactions |
EXP |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
EXP |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
decreases expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Cbr3 |
carbonyl reductase 3 |
|
increases expression |
ISO |
11 |
33,913,961 |
33,922,221 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
multiple interactions |
EXP |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
EXP |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
multiple interactions |
EXP |
19 |
10,697,324 |
10,704,129 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
EXP |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
increases expression |
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd28 |
Cd28 molecule |
|
increases expression |
EXP |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
EXP |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc23 |
cell division cycle 23 |
|
decreases expression |
EXP |
18 |
27,108,516 |
27,128,285 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
EXP |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
EXP |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
decreases expression |
ISO |
13 |
47,139,658 |
47,147,591 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
decreases activity |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
decreases expression |
EXP |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Clta |
clathrin, light chain A |
|
decreases expression |
EXP |
5 |
60,484,437 |
60,502,432 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
multiple interactions |
EXP |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
decreases expression |
EXP |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
increases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
affects expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
increases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
multiple interactions |
EXP |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
decreases expression |
EXP |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
EXP |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
decreases expression |
EXP |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
EXP |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
affects localization |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases activity |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
multiple interactions |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
decreases expression |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Cul2 |
cullin 2 |
|
multiple interactions |
ISO |
17 |
62,701,289 |
62,741,344 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
multiple interactions |
EXP |
14 |
17,250,648 |
17,253,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
increases expression |
EXP |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
multiple interactions |
EXP |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
EXP |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
decreases expression |
ISO |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
increases expression |
ISO |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
decreases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
|
increases expression |
EXP |
2 |
51,881,101 |
51,881,461 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
increases expression |
ISO |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dnajb11 |
DnaJ (Hsp40) homolog, subfamily B, member 11 |
|
decreases expression |
ISO |
11 |
80,360,406 |
80,376,870 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
decreases expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
decreases expression |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
decreases expression |
ISO |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
multiple interactions |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
increases expression |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
multiple interactions |
EXP |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
decreases expression |
EXP |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
|
decreases expression |
EXP |
4 |
30,496,410 |
30,809,622 |
RGD:6480464 |
CTD |
| G |
Edem1 |
ER degradation enhancer, mannosidase alpha-like 1 |
|
decreases expression |
ISO |
4 |
144,349,966 |
144,379,501 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
multiple interactions |
EXP |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
increases phosphorylation |
ISO |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
increases phosphorylation |
ISO |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
multiple interactions |
EXP |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
increases phosphorylation |
EXP |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
increases expression |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
decreases expression |
EXP |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
multiple interactions |
EXP |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Eprs |
glutamyl-prolyl-tRNA synthetase |
|
decreases expression |
ISO |
13 |
101,375,656 |
101,448,175 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose-1,6-bisphosphatase 2 |
|
increases expression |
ISO |
17 |
7,824,298 |
7,841,661 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
decreases expression |
EXP |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
EXP |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
multiple interactions |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
multiple interactions |
EXP |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
increases expression |
EXP |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
increases expression |
ISO |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
decreases expression |
EXP |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
decreases expression |
ISO |
7 |
137,490,985 |
137,494,418 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
|
decreases cleavage |
ISO |
1 |
136,209,969 |
136,222,057 |
RGD:6480464 |
CTD |
| G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
|
multiple interactions |
ISO |
1 |
136,209,969 |
136,222,057 |
RGD:6480464 |
CTD |
| G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
increases expression |
EXP |
8 |
48,379,075 |
48,385,553 |
RGD:6480464 |
CTD |
| G |
Gatm |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
decreases expression |
EXP |
3 |
109,558,043 |
109,565,432 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
decreases expression |
EXP |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
multiple interactions |
EXP |
4 |
121,204,274 |
121,250,160 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
increases expression |
ISO |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
|
decreases expression |
ISO |
15 |
21,272,165 |
21,284,459 |
RGD:6480464 |
CTD |
| G |
Gnptab |
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits |
|
increases expression |
ISO |
7 |
25,084,137 |
25,149,880 |
RGD:6480464 |
CTD |
| G |
Gpd1l |
glycerol-3-phosphate dehydrogenase 1-like |
|
increases expression |
ISO |
8 |
119,317,528 |
119,347,194 |
RGD:6480464 |
CTD |
| G |
Grem1 |
gremlin 1 |
|
multiple interactions |
EXP |
3 |
99,597,201 |
99,608,935 |
RGD:6480464 |
CTD |
| G |
Grem1 |
gremlin 1 |
|
decreases expression |
EXP |
3 |
99,597,201 |
99,608,935 |
RGD:6480464 |
CTD |
| G |
Gspt1 |
G1 to S phase transition 1 |
|
multiple interactions |
ISO |
10 |
4,249,196 |
4,283,833 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases expression |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
|
decreases expression |
EXP |
2 |
19,576,064 |
19,638,106 |
RGD:6480464 |
CTD |
| G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
|
multiple interactions |
EXP |
2 |
19,576,064 |
19,638,106 |
RGD:6480464 |
CTD |
| G |
Herpud1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
decreases expression |
ISO |
19 |
11,036,567 |
11,046,914 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hk1 |
hexokinase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hk1 |
hexokinase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmga1 |
high mobility group AT-hook 1 |
|
increases expression |
EXP |
20 |
5,769,052 |
5,772,269 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression |
ISO |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmmr |
hyaluronan mediated motility receptor (RHAMM) |
|
decreases expression |
EXP |
10 |
25,733,375 |
25,762,825 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
decreases expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
decreases expression |
EXP |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
decreases expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
decreases expression |
EXP |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
decreases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hyou1 |
hypoxia up-regulated 1 |
|
decreases expression |
ISO |
8 |
47,346,753 |
47,358,869 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases activity |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
increases expression |
ISO |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Ifi204 |
interferon activated gene 204 |
|
increases expression |
ISO |
13 |
89,752,997 |
89,770,167 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression |
ISO |
1 |
238,571,300 |
238,576,443 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases secretion |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
decreases expression |
ISO |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
increases expression |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
multiple interactions |
EXP |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
decreases expression |
EXP |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
multiple interactions |
EXP |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
multiple interactions |
EXP |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
EXP |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
multiple interactions |
EXP |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases secretion |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il23r |
interleukin 23 receptor |
|
multiple interactions |
EXP |
4 |
97,087,580 |
97,768,978 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
decreases expression |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases secretion |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
decreases secretion |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
decreases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
multiple interactions |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
increases expression |
EXP |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
multiple interactions |
EXP |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
increases expression |
EXP |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
multiple interactions |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
decreases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
multiple interactions |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
|
increases expression |
ISO |
10 |
100,514,180 |
100,515,949 |
RGD:6480464 |
CTD |
| G |
Kif11 |
kinesin family member 11 |
|
decreases expression |
EXP |
1 |
241,668,938 |
241,722,847 |
RGD:6480464 |
CTD |
| G |
Kif4a |
kinesin family member 4A |
|
decreases expression |
EXP |
X |
88,624,683 |
88,742,447 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
increases expression |
ISO |
7 |
73,821,190 |
73,826,866 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
multiple interactions |
EXP |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
increases expression |
EXP |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
multiple interactions |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
multiple interactions |
ISO |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
decreases expression |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
multiple interactions |
EXP |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
decreases expression |
EXP |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
increases expression |
EXP |
3 |
151,116,831 |
151,118,751 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2a |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2a |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2a |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2a |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mfap3l |
microfibrillar-associated protein 3-like |
|
increases expression |
ISO |
16 |
32,751,464 |
32,766,478 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
decreases expression |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 (stromelysin 2) |
|
increases expression |
EXP |
8 |
4,367,842 |
4,375,737 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 (stromelysin 2) |
|
multiple interactions |
EXP |
8 |
4,367,842 |
4,375,737 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
multiple interactions |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
increases expression |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
affects expression |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
decreases expression |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
EXP |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
EXP |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases expression |
EXP |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
decreases activity |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
increases expression |
ISO |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Ndufa4 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 |
|
increases expression |
EXP |
4 |
37,125,782 |
37,133,055 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
8 |
77,252,500 |
77,337,402 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases activity |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases phosphorylation |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
multiple interactions |
EXP |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
increases expression |
EXP |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Ngef |
neuronal guanine nucleotide exchange factor |
|
increases expression |
ISO |
9 |
86,294,206 |
86,327,765 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
affects expression |
EXP |
7 |
26,189,759 |
26,307,061 |
RGD:6480464 |
CTD |
| G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
|
increases expression |
ISO |
X |
158,923,025 |
158,954,914 |
RGD:6480464 |
CTD |
| G |
Nucb2 |
nucleobindin 2 |
|
decreases expression |
ISO |
1 |
174,605,677 |
174,642,111 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
decreases expression |
EXP |
13 |
85,286,634 |
85,315,366 |
RGD:6480464 |
CTD |
| G |
Oasl2 |
2'-5' oligoadenylate synthetase-like 2 |
|
increases expression |
ISO |
12 |
42,996,518 |
43,009,338 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
multiple interactions |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
decreases expression |
ISO |
X |
89,721,369 |
89,766,218 |
RGD:6480464 |
CTD |
| G |
Orc2 |
origin recognition complex, subunit 2 |
|
decreases expression |
ISO |
9 |
57,125,684 |
57,155,508 |
RGD:6480464 |
CTD |
| G |
Oxr1 |
oxidation resistance 1 |
|
decreases expression |
ISO |
7 |
77,427,877 |
77,501,800 |
RGD:6480464 |
CTD |
| G |
Pank1 |
pantothenate kinase 1 |
|
increases expression |
ISO |
1 |
238,797,912 |
238,857,586 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
affects expression |
EXP |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
EXP |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
decreases expression |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pfkp |
phosphofructokinase, platelet |
|
increases expression |
ISO |
17 |
74,760,912 |
74,823,046 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
decreases expression |
ISO |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
decreases expression |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
affects expression |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
multiple interactions |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
multiple interactions |
EXP |
5 |
157,619,703 |
157,640,971 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
decreases expression |
EXP |
5 |
157,619,703 |
157,640,971 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
increases expression |
ISO |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
decreases expression |
EXP |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
decreases expression |
EXP |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
decreases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
decreases expression |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppm1a |
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
|
decreases expression |
ISO |
6 |
95,162,067 |
95,198,936 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
decreases expression |
ISO |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
decreases expression |
EXP |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Psme3 |
proteasome (prosome, macropain) activator subunit 3 |
|
decreases expression |
ISO |
10 |
90,343,493 |
90,351,335 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
ISO |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
ISO |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases glycosylation |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
decreases expression |
EXP |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Rab32 |
RAB32, member RAS oncogene family |
|
increases expression |
ISO |
1 |
5,203,908 |
5,218,416 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
decreases expression |
EXP |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Rbm39 |
RNA binding motif protein 39 |
|
decreases expression |
ISO |
3 |
146,555,202 |
146,587,650 |
RGD:6480464 |
CTD |
| G |
Recql4 |
RecQ protein-like 4 |
|
increases expression |
ISO |
7 |
114,752,863 |
114,760,027 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases localization |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
ISO |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhoc |
ras homolog family member C |
|
decreases expression |
ISO |
2 |
200,048,056 |
200,054,107 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
multiple interactions |
ISO |
7 |
137,418,519 |
137,425,590 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
decreases expression |
ISO |
7 |
137,418,519 |
137,425,590 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases phosphorylation |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases phosphorylation |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases phosphorylation |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
multiple interactions |
EXP |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
decreases expression |
EXP |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
multiple interactions |
EXP |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
decreases expression |
EXP |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Selenbp1 |
selenium binding protein 1 |
|
decreases expression |
EXP |
2 |
189,840,450 |
189,881,332 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
EXP |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
increases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
decreases expression |
EXP |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
decreases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
decreases expression |
EXP |
16 |
90,002,645 |
90,022,167 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
increases expression |
EXP |
3 |
119,796,376 |
119,886,011 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases uptake |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a6 |
solute carrier family 2 (facilitated glucose transporter), member 6 |
|
decreases expression |
ISO |
3 |
5,917,992 |
5,924,807 |
RGD:6480464 |
CTD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
increases expression |
ISO |
8 |
47,363,896 |
47,369,981 |
RGD:6480464 |
CTD |
| G |
Slc4a4 |
solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
decreases expression |
EXP |
14 |
20,381,545 |
20,739,216 |
RGD:6480464 |
CTD |
| G |
Slc7a8 |
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
|
increases expression |
EXP |
15 |
32,800,927 |
32,860,797 |
RGD:6480464 |
CTD |
| G |
Slc7a8 |
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
|
multiple interactions |
EXP |
15 |
32,800,927 |
32,860,797 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
multiple interactions |
ISO |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
increases phosphorylation |
ISO |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral membrane |
|
decreases expression |
EXP |
19 |
36,112,166 |
36,195,564 |
RGD:6480464 |
CTD |
| G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
multiple interactions |
EXP |
17 |
42,172,863 |
42,177,590 |
RGD:6480464 |
CTD |
| G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
decreases expression |
EXP |
17 |
42,172,863 |
42,177,590 |
RGD:6480464 |
CTD |
| G |
Srsf3 |
serine/arginine-rich splicing factor 3 |
|
decreases expression |
ISO |
20 |
7,316,649 |
7,326,580 |
RGD:6480464 |
CTD |
| G |
St6gal1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
increases expression |
ISO |
11 |
79,723,269 |
79,765,645 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
|
decreases expression |
EXP |
14 |
82,746,460 |
82,760,864 |
RGD:6480464 |
CTD |
| G |
Testin |
testin gene |
|
decreases expression |
EXP |
17 |
9,532,437 |
9,544,923 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
multiple interactions |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Thbs4 |
thrombospondin 4 |
|
multiple interactions |
EXP |
2 |
23,010,823 |
23,053,527 |
RGD:6480464 |
CTD |
| G |
Thbs4 |
thrombospondin 4 |
|
decreases expression |
EXP |
2 |
23,010,823 |
23,053,527 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
affects expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
multiple interactions |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
multiple interactions |
EXP |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
EXP |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tinag |
tubulointerstitial nephritis antigen |
|
increases expression |
ISO |
8 |
81,947,234 |
82,032,994 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tlr1 |
toll-like receptor 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
multiple interactions |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
multiple interactions |
EXP |
11 |
69,927,509 |
69,966,854 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
3 |
86,827,582 |
86,847,408 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
increases expression |
ISO |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
decreases expression |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
decreases expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
multiple interactions |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
EXP |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
decreases expression |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
|
increases expression |
ISO |
5 |
136,255,481 |
136,263,676 |
RGD:6480464 |
CTD |
| G |
Vamp1 |
vesicle-associated membrane protein 1 |
|
increases expression |
EXP |
4 |
161,333,661 |
161,340,447 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
multiple interactions |
EXP |
2 |
19,712,629 |
19,801,443 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
decreases expression |
EXP |
2 |
19,712,629 |
19,801,443 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
increases expression |
ISO |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
multiple interactions |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
decreases splicing |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases expression |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
increases expression |
EXP |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
multiple interactions |
EXP |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Zfp467 |
zinc finger protein 467 |
|
increases expression |
ISO |
4 |
76,522,000 |
76,528,470 |
RGD:6480464 |
CTD |
beta-D-glucosamine
|
| G |
Aacs |
acetoacetyl-CoA synthetase |
|
increases expression |
ISO |
12 |
32,206,863 |
32,250,583 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
increases expression |
EXP |
20 |
9,390,485 |
9,459,574 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
EXP |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
increases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
affects expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
decreases expression |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acan |
aggrecan |
|
multiple interactions |
ISO |
1 |
134,787,341 |
134,848,992 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
increases expression |
ISO |
6 |
108,089,349 |
108,095,288 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
decreases expression |
ISO |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
|
increases expression |
ISO |
3 |
146,013,995 |
146,057,119 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
multiple interactions |
EXP |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
decreases expression |
EXP |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
multiple interactions |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
increases expression |
EXP |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
decreases expression |
ISO |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
multiple interactions |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
decreases expression |
EXP |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
|
increases expression |
EXP |
13 |
87,142,442 |
87,151,783 |
RGD:6480464 |
CTD |
| G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
|
decreases expression |
ISO |
11 |
25,503,380 |
25,548,851 |
RGD:6480464 |
CTD |
| G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
|
multiple interactions |
ISO |
11 |
25,503,380 |
25,548,851 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
decreases cleavage |
ISO |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Ahi1 |
Abelson helper integration site 1 |
|
decreases expression |
ISO |
1 |
16,332,801 |
16,454,055 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
increases expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alg12 |
asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase |
|
decreases expression |
ISO |
7 |
127,109,296 |
127,123,482 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases activity |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases secretion |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases stability |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases degradation |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases localization |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
decreases secretion |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases ubiquitination |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
multiple interactions |
EXP |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
decreases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
multiple interactions |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
decreases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
multiple interactions |
EXP |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
EXP |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atf7ip |
activating transcription factor 7 interacting protein |
|
increases expression |
ISO |
4 |
173,566,920 |
173,586,494 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Azin1 |
antizyme inhibitor 1 |
|
decreases expression |
EXP |
7 |
74,159,130 |
74,189,447 |
RGD:6480464 |
CTD |
| G |
Azin1 |
antizyme inhibitor 1 |
|
multiple interactions |
EXP |
7 |
74,159,130 |
74,189,447 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
multiple interactions |
EXP |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
increases expression |
EXP |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
multiple interactions |
EXP |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
increases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
multiple interactions |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
decreases expression |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
EXP |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
multiple interactions |
EXP |
17 |
32,380,199 |
32,689,295 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
decreases expression |
EXP |
17 |
32,380,199 |
32,689,295 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
multiple interactions |
EXP |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
EXP |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
decreases expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Cbr3 |
carbonyl reductase 3 |
|
increases expression |
ISO |
11 |
33,913,961 |
33,922,221 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
multiple interactions |
EXP |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
EXP |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
multiple interactions |
EXP |
19 |
10,697,324 |
10,704,129 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
EXP |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
increases expression |
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd28 |
Cd28 molecule |
|
increases expression |
EXP |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
EXP |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc23 |
cell division cycle 23 |
|
decreases expression |
EXP |
18 |
27,108,516 |
27,128,285 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
EXP |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
EXP |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
decreases expression |
ISO |
13 |
47,139,658 |
47,147,591 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
decreases activity |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
decreases expression |
EXP |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Clta |
clathrin, light chain A |
|
decreases expression |
EXP |
5 |
60,484,437 |
60,502,432 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
multiple interactions |
EXP |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
decreases expression |
EXP |
2 |
209,996,467 |
210,193,379 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
increases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
affects expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
increases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
EXP |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
multiple interactions |
EXP |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Col8a1 |
collagen, type VIII, alpha 1 |
|
decreases expression |
EXP |
11 |
43,604,994 |
43,733,870 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
EXP |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
decreases expression |
EXP |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
EXP |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
affects localization |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases activity |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
multiple interactions |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
decreases expression |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Cul2 |
cullin 2 |
|
multiple interactions |
ISO |
17 |
62,701,289 |
62,741,344 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
EXP |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
multiple interactions |
EXP |
14 |
17,250,648 |
17,253,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
increases expression |
EXP |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
multiple interactions |
EXP |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Eprs |
glutamyl-prolyl-tRNA synthetase |
|
decreases expression |
ISO |
13 |
101,375,656 |
101,448,175 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose-1,6-bisphosphatase 2 |
|
increases expression |
ISO |
17 |
7,824,298 |
7,841,661 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
decreases expression |
EXP |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
multiple interactions |
EXP |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
multiple interactions |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
multiple interactions |
EXP |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
increases expression |
EXP |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
increases expression |
ISO |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Figf |
c-fos induced growth factor |
|
decreases expression |
EXP |
X |
50,830,612 |
50,864,445 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
decreases expression |
ISO |
7 |
137,490,985 |
137,494,418 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Hmmr |
hyaluronan mediated motility receptor (RHAMM) |
|
decreases expression |
EXP |
10 |
25,733,375 |
25,762,825 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
decreases expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
decreases expression |
EXP |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
decreases expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
decreases expression |
EXP |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
decreases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hyou1 |
hypoxia up-regulated 1 |
|
decreases expression |
ISO |
8 |
47,346,753 |
47,358,869 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases secretion |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
increases expression |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
multiple interactions |
EXP |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
decreases expression |
EXP |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Il11 |
interleukin 11 |
|
multiple interactions |
EXP |
1 |
67,784,584 |
67,795,141 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
multiple interactions |
EXP |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
EXP |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
multiple interactions |
EXP |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases secretion |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases secretion |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
decreases secretion |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
multiple interactions |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
decreases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
multiple interactions |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
|
increases expression |
ISO |
10 |
100,514,180 |
100,515,949 |
RGD:6480464 |
CTD |
| G |
Kif11 |
kinesin family member 11 |
|
decreases expression |
EXP |
1 |
241,668,938 |
241,722,847 |
RGD:6480464 |
CTD |
| G |
Kif4a |
kinesin family member 4A |
|
decreases expression |
EXP |
X |
88,624,683 |
88,742,447 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
increases expression |
ISO |
7 |
73,821,190 |
73,826,866 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
multiple interactions |
EXP |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
increases expression |
EXP |
20 |
43,077,612 |
43,203,519 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
multiple interactions |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
multiple interactions |
ISO |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
decreases expression |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
multiple interactions |
EXP |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
LOC100360218 |
interleukin 13 receptor, alpha 1-like |
|
decreases expression |
EXP |
11 |
73,147,318 |
73,148,958 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
increases expression |
EXP |
3 |
151,116,831 |
151,118,751 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 (stromelysin 2) |
|
increases expression |
EXP |
8 |
4,367,842 |
4,375,737 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 (stromelysin 2) |
|
multiple interactions |
EXP |
8 |
4,367,842 |
4,375,737 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
multiple interactions |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
increases expression |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
affects expression |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases activity |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
affects expression |
EXP |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
EXP |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
decreases expression |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
increases expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Pfkp |
phosphofructokinase, platelet |
|
increases expression |
ISO |
17 |
74,760,912 |
74,823,046 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
decreases expression |
ISO |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
decreases expression |
EXP |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
affects expression |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
multiple interactions |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
multiple interactions |
EXP |
5 |
157,619,703 |
157,640,971 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
decreases expression |
EXP |
5 |
157,619,703 |
157,640,971 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
increases expression |
ISO |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
decreases expression |
EXP |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
decreases expression |
EXP |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Rab32 |
RAB32, member RAS oncogene family |
|
increases expression |
ISO |
1 |
5,203,908 |
5,218,416 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
decreases expression |
EXP |
7 |
138,366,356 |
138,395,716 |
RGD:6480464 |
CTD |
| G |
Rbm39 |
RNA binding motif protein 39 |
|
decreases expression |
ISO |
3 |
146,555,202 |
146,587,650 |
RGD:6480464 |
CTD |
| G |
Recql4 |
RecQ protein-like 4 |
|
increases expression |
ISO |
7 |
114,752,863 |
114,760,027 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
increases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
decreases expression |
EXP |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
decreases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Shcbp1 |
Shc SH2-domain binding protein 1 |
|
decreases expression |
EXP |
16 |
90,002,645 |
90,022,167 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
increases expression |
EXP |
3 |
119,796,376 |
119,886,011 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases uptake |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
multiple interactions |
EXP |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
affects expression |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
EXP |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
multiple interactions |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
multiple interactions |
EXP |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
EXP |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tinag |
tubulointerstitial nephritis antigen |
|
increases expression |
ISO |
8 |
81,947,234 |
82,032,994 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tlr1 |
toll-like receptor 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
3 |
86,827,582 |
86,847,408 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
increases expression |
ISO |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
decreases expression |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
decreases expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
multiple interactions |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
EXP |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
decreases expression |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
|
increases expression |
ISO |
5 |
136,255,481 |
136,263,676 |
RGD:6480464 |
CTD |
| G |
Vamp1 |
vesicle-associated membrane protein 1 |
|
increases expression |
EXP |
4 |
161,333,661 |
161,340,447 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
multiple interactions |
EXP |
2 |
19,712,629 |
19,801,443 |
RGD:6480464 |
CTD |
| G |
Vcan |
versican |
|
decreases expression |
EXP |
2 |
19,712,629 |
19,801,443 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
increases expression |
ISO |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
multiple interactions |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
decreases splicing |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
Term paths to the root
|